StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Mosaic ImmunoEngineering's operating cash flow for the twelve months ending Jun 30, 2026 was -$53.56K. For fiscal 2025 it was -$111.40K. The highest annual figure on record is -$111.40K in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$111.40K–
FY2024Dec 31, 2024-$241.16K–
FY2023Dec 31, 2023-$497.47K–
FY2022Dec 31, 2022-$690.13K–
FY2020May 31, 2020-$986.76K–
FY2019May 31, 2019-$760.77K–
FY2018May 31, 2018-$880.17K–
FY2017May 31, 2017-$1.31M–
FY2016May 31, 2016-$1.58M–
FY2015May 31, 2015-$1.34M–
FY2014May 31, 2014-$1.50M–
FY2013May 31, 2013-$1.01M–
FY2012May 31, 2012-$2.40M–
FY2011May 31, 2011-$4.32M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$46–
Q1 FY2026CQ1 2026Mar 31, 2026-$3.55K–
Q4 FY2025CQ4 2025Dec 31, 2025-$28.14K–
Q3 FY2025CQ3 2025Sep 30, 2025-$21.82K–
Q2 FY2025CQ2 2025Jun 30, 2025-$32.35K–
Q1 FY2025CQ1 2025Mar 31, 2025-$29.09K–
Q4 FY2024CQ4 2024Dec 31, 2024-$20.72K–
Q3 FY2024CQ3 2024Sep 30, 2024-$13.00K–
Q2 FY2024CQ2 2024Jun 30, 2024-$116.31K–
Q1 FY2024CQ1 2024Mar 31, 2024-$91.14K–
Q4 FY2023CQ4 2023Dec 31, 2023-$96.72K–
Q3 FY2023CQ3 2023Sep 30, 2023-$110.07K–
Q2 FY2023CQ2 2023Jun 30, 2023-$118.81K–
Q1 FY2023CQ1 2023Mar 31, 2023-$171.87K–
Q4 FY2022CQ4 2022Dec 31, 2022-$163.49K–
Q3 FY2022CQ3 2022Sep 30, 2022-$164.86K–
Q2 FY2022CQ2 2022Jun 30, 2022-$172.06K–
Q1 FY2022CQ1 2022Mar 31, 2022-$189.72K–
Q4 FY2020CQ2 2020May 31, 2020-$176.91K–
Q3 FY2020CQ1 2020Feb 29, 2020-$214.12K–
Q2 FY2020CQ4 2019Nov 30, 2019-$275.71K–
Q1 FY2020CQ3 2019Aug 31, 2019-$320.02K–
Q4 FY2019CQ2 2019May 31, 2019-$229.12K–
Q3 FY2019CQ1 2019Feb 28, 2019-$106.99K–
Q2 FY2019CQ4 2018Nov 30, 2018-$164.34K–
Q1 FY2019CQ3 2018Aug 31, 2018-$260.33K–
Q4 FY2018CQ2 2018May 31, 2018-$209.35K–
Q3 FY2018CQ1 2018Feb 28, 2018-$186.43K–
Q2 FY2018CQ4 2017Nov 30, 2017-$255.47K–
Q1 FY2018CQ3 2017Aug 31, 2017-$228.92K–
Q4 FY2017CQ2 2017May 31, 2017-$386.07K–
Q3 FY2017CQ1 2017Feb 28, 2017-$230.99K–
Q2 FY2017CQ4 2016Nov 30, 2016-$274.59K–
Q1 FY2017CQ3 2016Aug 31, 2016-$419.19K–
Q4 FY2016CQ2 2016May 31, 2016-$360.08K–
Q3 FY2016CQ1 2016Feb 29, 2016-$358.97K–
Q2 FY2016CQ4 2015Nov 30, 2015-$307.81K–
Q1 FY2016CQ3 2015Aug 31, 2015-$551.42K–
Q4 FY2015CQ2 2015May 31, 2015-$332.61K–
Q3 FY2015CQ1 2015Feb 28, 2015-$212.55K–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?